Abstract:BACKGROUND:Ovarian cancer is a common malignancy in the female reproductive system with a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer chemotherapy. To reduce side effects, reverse resistance and improve efficacy for the treatment of ovarian cancer, a "core-shell" polymeric nanoparticle-mediated curcumin and paclitaxel co-delivery platform was designed.METHODS:Nuclear magnetic resonance confirmed the successful grafting of polyethylenimine (PEI) and stearic acid (SA) (PEI-SA), which is designed as a mother core for transport carrier. Then, PEI-SA was modified with hyaluronic acid (HA) and physicochemical properties were examined. To understand the regulatory mechanism of resistance and measure the anti-tumor efficacy of the treatments, cytotoxicity assay, cellular uptake, P-glycoprotein (P-gp) expression and migration experiment of ovarian cancer cells were performed. In addition, adverse reactions of nanoformulation to the reproductive system were examined.RESULTS:HA-modified drug-loaded PEI-SA had a narrow size of about 189 nm in diameters, and the particle size was suitable for endocytosis. The nanocarrier could target specifically to CD44 receptor on the ovarian cancer cell membrane. Co-delivery of curcumin and paclitaxel by the nanocarriers exerts synergistic anti-ovarian cancer effects on chemosensitive human ovarian cancer cells (SKOV3) and multi-drug resistant variant (SKOV3-TR30) in vitro, and it also shows a good anti-tumor effect in ovarian tumor-bearing nude mice. The mechanism of reversing drug resistance may be that the nanoparticles inhibit the efflux of P-gp, inhibit the migration of tumor cells, and curcumin synergistically reverses the resistance of PTX to increase antitumor activity. It is worth noting that the treatment did not cause significant toxicity to the uterus and ovaries with the observation of macroscopic and microscopic.CONCLUSION:This special structure of targeting nanoparticles co-delivery with the curcumin and paclitaxel can increase the anti-tumor efficacy without increasing the adverse reactions as a promising strategy for therapy ovarian cancer.

Cu(II) and Co(II) Coordination Polymers: Protective Activity on the Ovarian Injury Caused by Chemotherapy by Enhancing the Secretion of Vascular Endothelial Growth Factor

Two Metal–Organic Coordination Polymers Based on Polypyridyl Ligands: Crystal Structures and Inhibition of Human Spinal Tumour Cells

Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.

New Ag(I) and Cu(I) coordination polymers containing N-donor ligands: Structural characterization and anti-ovarian cancer activity study

Two Coordination Polymers: Fluorescence Performances and Loaded with Gel-Paclitaxel on Ovarian Cancer Treatment

Cu(II) and Co(II) coordination polymers: Magnetic properties, regulating the YAP signaling pathway activation and exerting anticancer activity against breast cancer combined with Sevoflurane

Cu(II)-Coordination Polymer Nanostructures Induce Human Lung Cancer Cell Carcinoma Apoptotic Cell Death In Vitro and In Vivo

Cervical cancer treatment of Co(II) coordination polymer through miR-9-5p-regulated BRCA1-OCT1-GADD45 pathways

Synthesis and anticancer property of three new Cu(II) coordination polymers constructed by the bifunctional substituted-polynitrogen heterocyclic ligands

Two Cu(II)-based coordination polymers: Enhancement on acupuncture treatment activity during salpingitis

Two new coordination polymers: Magnetic properties and treatment activity on non-small cell lung cancer by reversing the resistance of the cancer cells

Treatment of Polycystic Ovary Syndrome by Two Silver(I)-Based Coordination Polymers by Modulating the Release of Chronic Inflammatory Cytokines

Synthesis, Structure and in Vitro Anti-gastric Cancer Activity of Two New Mixed-Ligand Cu(II) and Cd(II)-Coordination Polymers

Two mixed-ligand Cu(II) coordination polymers: Magnetic properties and inhibitory activity on the osteosarcoma by reducing the expression of the estrogen receptor

Two new coordination polymers: Magnetic properties and treatment activity on the wound healing after facial plastic surgery by inhibiting the vascular endothelial growth factor signaling pathway

The EZH2-H3K27me3 axis modulates aberrant transcription and apoptosis in cyclophosphamide-induced ovarian granulosa cell injury

Doxorubicin-Fe(III)-Gossypol Infinite Coordination Polymer@PDA:CuO 2 Composite Nanoparticles for Cost-Effective Programmed Photothermal-Chemodynamic-Coordinated Dual Drug Chemotherapy Trimodal Synergistic Tumor Therapy

Zn(II) and Co(II)-Based MOFs for Fe3+ion Fluorescence Sensing and Used as Metal Paclitaxel-gel Particles on Nasopharyngeal Carcinoma Treatment

Co(II)-coordination Complex: Fluorescence Performances and Combined with Taxotere-Hydrogels on Breast Cancer Treatment and Clinical Care

Treatment effect of Co(II)-coordination polymers on postpartum depression by regulating 5-HT content

Cu(II)-based complex loaded with drug paclitaxel hydrogels against thyroid cancer and optimizing novel derivatives